Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides (Q66984871)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

title

Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

1 reference

26 June 2023

1 reference

26 June 2023

author name string

G. Peter

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A527208

9 July 2022

H. J. Hohorst

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A527208

9 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=527208

9 July 2022

publication date

1 January 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

1 September 2019

http://link.springer.com/content/pdf/10.1007/BF00262420.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00262420/fulltext.html

26 June 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00262420

26 June 2023

1 reference

Cancer Chemotherapy and Pharmacology

26 June 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

page(s)

181-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00262420

1 September 2019

exact match

0 references

cites work

Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds

1 reference

12 December 2020

Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry

1 reference

12 December 2020

Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds

1 reference

12 December 2020

On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)

1 reference

12 December 2020

Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions

1 reference

12 December 2020

Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative

1 reference

12 December 2020

Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives

1 reference

12 December 2020

The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity

1 reference

12 December 2020

Fluorometric determination of "activated" cyclophosphamide and ifosfamide in blood (author's transl)

1 reference

12 December 2020

Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds

1 reference

12 December 2020

Techniques for the demonstration by chromatography of nitrogenous lipide constituents, sulfur-containing amino acids, and reducing sugars

1 reference

12 December 2020

Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity

1 reference

12 December 2020

Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo

1 reference

12 December 2020

[Studies on the spontaneous decomposition of 4-hydroxyphosphamide and 4-hydroperoxyphosphamide by means of thin-layer chromatography]

1 reference

12 December 2020

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide

1 reference

12 December 2020

ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00262420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:527208%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 September 2019

0 references

1 reference